Increase in Bone Mass and Bone Strength by Sambucus williamsii HANCE in Ovariectomized Rats
Herbal Sambucus williamsii HANCE (SWH) is a folk medicine with a long history of safe use for treatment of bone fractures and joint diseases in China. The present study was designed to investigate if SWH extract could be used for treatment of postmenopausal osteoporosis. SWH extracts (30 or 60 mg/10...
Gespeichert in:
| Veröffentlicht in: | Biological & Pharmaceutical Bulletin 2005, Vol.28(10), pp.1879-1885 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1885 |
|---|---|
| container_issue | 10 |
| container_start_page | 1879 |
| container_title | Biological & Pharmaceutical Bulletin |
| container_volume | 28 |
| creator | Xie, Fang Wu, Chun-Fu Zhang, Yan Yao, Xin-Sheng Cheung, Pik-Yuen Chan, Albert Sun-Chi Wong, Man-Sau |
| description | Herbal Sambucus williamsii HANCE (SWH) is a folk medicine with a long history of safe use for treatment of bone fractures and joint diseases in China. The present study was designed to investigate if SWH extract could be used for treatment of postmenopausal osteoporosis. SWH extracts (30 or 60 mg/100 g body weight/d) were orally administrated to four-months-old ovariectomized (OVX) rats for 3 months. SWH extracts did not alter weight gain and uterus weight in OVX rats. SWH extracts significantly increased serum Ca levels (p |
| doi_str_mv | 10.1248/bpb.28.1879 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68653603</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68653603</sourcerecordid><originalsourceid>FETCH-LOGICAL-c722t-c7184f0674fedc1ea2c55d80e3ff117286170de9e7b16cecc068dadc87ba7c793</originalsourceid><addsrcrecordid>eNqFkc1v1DAQxS0EokvhxB1FQuJS7eJx4o8c21W_pEIlCicOluNMWq8Se7ETUPnr8TZLK3HhMpY1P783nkfIW6ArYJX62GybFVMrULJ-RhZQVnLJGfDnZEFrUEsBXB2QVyltKKWSsvIlOQDBaFWX9YJ8v_Q2oklYOF-cBI_FJ5NSYXw7327GiP52vCua--LGDM1kp1T8cn3vzJCcKy6OP69Pd2-vf5ro0I5hcL-xLb6YMb0mLzrTJ3yzPw_Jt7PTr-uL5dX1-eX6-GppJWNjrqCqjgpZddhaQMMs562iWHYdgGRKgKQt1igbEBatpUK1prVKNkZaWZeH5MOsu43hx4Rp1INLFvveeAxT0kIJXgpa_hfMPrwSDDL4_h9wE6bo8yc0VHlxHIRSmTqaKRtDShE7vY1uMPFeA9W7aHSORjOld9Fk-t1ec2oGbJ_YfRYZOJ-B3HXW9MH3zuOTs02ycaEPmlHKNaVMZRsK7EE-F8Uhb6ZmPCudzEqbNJpbfLQycXS2x8ex6L4-CPxt2jsTNfryD-Oetlo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1449351688</pqid></control><display><type>article</type><title>Increase in Bone Mass and Bone Strength by Sambucus williamsii HANCE in Ovariectomized Rats</title><source>J-STAGE Free</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Xie, Fang ; Wu, Chun-Fu ; Zhang, Yan ; Yao, Xin-Sheng ; Cheung, Pik-Yuen ; Chan, Albert Sun-Chi ; Wong, Man-Sau</creator><creatorcontrib>Xie, Fang ; Wu, Chun-Fu ; Zhang, Yan ; Yao, Xin-Sheng ; Cheung, Pik-Yuen ; Chan, Albert Sun-Chi ; Wong, Man-Sau ; aDepartment of Pharmacology ; Shenyang Pharmaceutical University ; Department of Applied Biology and Chemical Technology ; The Hong Kong Polytechnic University ; cState Key Laboratory of Chinese Medicine and Molecular Pharmacology ; bOpen Laboratory of Chirotechnology of the Institute of Molecular Technology for Drug Discovery and Synthesis</creatorcontrib><description><![CDATA[Herbal Sambucus williamsii HANCE (SWH) is a folk medicine with a long history of safe use for treatment of bone fractures and joint diseases in China. The present study was designed to investigate if SWH extract could be used for treatment of postmenopausal osteoporosis. SWH extracts (30 or 60 mg/100 g body weight/d) were orally administrated to four-months-old ovariectomized (OVX) rats for 3 months. SWH extracts did not alter weight gain and uterus weight in OVX rats. SWH extracts significantly increased serum Ca levels (p<0.05, vs. OVX control group) as well as decreased urinary Ca excretion (p<0.01, vs. OVX control group) in OVX rats. The upregulation of serum alkaline phosphatase, serum osteocalcin as well as urinary deoxypyridinoline levels by OVX was suppressed by treatment with SWH extracts in rats (p<0.05, vs. OVX control group). SWH extract increased the stiffness of femur at both dosage (p<0.05, vs. OVX control group) and increased tibial bone mineral density at 60 mg/100 g body weight/d (p<0.05, vs. OVX control group) in OVX rats. Our results indicate that orally administrated SWH extracts can decrease urinary calcium excretion and bone turnover rate in OVX rats, resulting in positive effects on biomechanical strength of bone and bone mineral density. This study is the first to report that SWH could be considered as a potential candidate for management of postmenopausal osteoporosis. Then in vitro experiments were performed to determine the potential molecular mechanism of the anti-osteoporotic effect of SWH. Results suggested that chloroform fraction and ethyl acetate fraction of SWH can inhibit osteoclastogenesis osteoclast by modulating the expression of osteoprotegrin (OPG) and receptor activator of NF-κB ligand (RANKL) mRNA in osteoblastic UMR 106 cells. Both of them increased OPG mRNA and decreased RANKL mRNA expression, resulting in a dose-dependent increase in OPG/RANKL mRNA ratio (p<0.01, vs. vehicle-treated). Taken together, SWH treatment can effectively suppress the OVX-induced increase in bone turnover and its effects might be mediated by a decrease in osteoclastogenesis.]]></description><identifier>ISSN: 0918-6158</identifier><identifier>EISSN: 1347-5215</identifier><identifier>DOI: 10.1248/bpb.28.1879</identifier><identifier>PMID: 16204939</identifier><language>eng</language><publisher>Japan: The Pharmaceutical Society of Japan</publisher><subject>Animals ; Base Sequence ; Biomechanical Phenomena ; Body Weight - drug effects ; Bone and Bones - drug effects ; bone mineral density ; bone strength OPG ; Carrier Proteins - genetics ; Cell Line ; DNA Primers ; Female ; Glycoproteins - genetics ; Membrane Glycoproteins - genetics ; Organ Size - drug effects ; Osteoporosis - drug therapy ; Osteoprotegerin ; ovariectomized rat ; Ovariectomy ; RANK Ligand ; RANKL ; Rats ; Rats, Sprague-Dawley ; Receptors, Cytoplasmic and Nuclear - genetics ; Receptors, Tumor Necrosis Factor - genetics ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Messenger - genetics ; Sambucus ; Sambucus williamsii ; Uterus - drug effects</subject><ispartof>Biological and Pharmaceutical Bulletin, 2005, Vol.28(10), pp.1879-1885</ispartof><rights>2005 The Pharmaceutical Society of Japan</rights><rights>Copyright Japan Science and Technology Agency 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c722t-c7184f0674fedc1ea2c55d80e3ff117286170de9e7b16cecc068dadc87ba7c793</citedby><cites>FETCH-LOGICAL-c722t-c7184f0674fedc1ea2c55d80e3ff117286170de9e7b16cecc068dadc87ba7c793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,1884,27926,27927</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16204939$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xie, Fang</creatorcontrib><creatorcontrib>Wu, Chun-Fu</creatorcontrib><creatorcontrib>Zhang, Yan</creatorcontrib><creatorcontrib>Yao, Xin-Sheng</creatorcontrib><creatorcontrib>Cheung, Pik-Yuen</creatorcontrib><creatorcontrib>Chan, Albert Sun-Chi</creatorcontrib><creatorcontrib>Wong, Man-Sau</creatorcontrib><creatorcontrib>aDepartment of Pharmacology</creatorcontrib><creatorcontrib>Shenyang Pharmaceutical University</creatorcontrib><creatorcontrib>Department of Applied Biology and Chemical Technology</creatorcontrib><creatorcontrib>The Hong Kong Polytechnic University</creatorcontrib><creatorcontrib>cState Key Laboratory of Chinese Medicine and Molecular Pharmacology</creatorcontrib><creatorcontrib>bOpen Laboratory of Chirotechnology of the Institute of Molecular Technology for Drug Discovery and Synthesis</creatorcontrib><title>Increase in Bone Mass and Bone Strength by Sambucus williamsii HANCE in Ovariectomized Rats</title><title>Biological & Pharmaceutical Bulletin</title><addtitle>Biol Pharm Bull</addtitle><description><![CDATA[Herbal Sambucus williamsii HANCE (SWH) is a folk medicine with a long history of safe use for treatment of bone fractures and joint diseases in China. The present study was designed to investigate if SWH extract could be used for treatment of postmenopausal osteoporosis. SWH extracts (30 or 60 mg/100 g body weight/d) were orally administrated to four-months-old ovariectomized (OVX) rats for 3 months. SWH extracts did not alter weight gain and uterus weight in OVX rats. SWH extracts significantly increased serum Ca levels (p<0.05, vs. OVX control group) as well as decreased urinary Ca excretion (p<0.01, vs. OVX control group) in OVX rats. The upregulation of serum alkaline phosphatase, serum osteocalcin as well as urinary deoxypyridinoline levels by OVX was suppressed by treatment with SWH extracts in rats (p<0.05, vs. OVX control group). SWH extract increased the stiffness of femur at both dosage (p<0.05, vs. OVX control group) and increased tibial bone mineral density at 60 mg/100 g body weight/d (p<0.05, vs. OVX control group) in OVX rats. Our results indicate that orally administrated SWH extracts can decrease urinary calcium excretion and bone turnover rate in OVX rats, resulting in positive effects on biomechanical strength of bone and bone mineral density. This study is the first to report that SWH could be considered as a potential candidate for management of postmenopausal osteoporosis. Then in vitro experiments were performed to determine the potential molecular mechanism of the anti-osteoporotic effect of SWH. Results suggested that chloroform fraction and ethyl acetate fraction of SWH can inhibit osteoclastogenesis osteoclast by modulating the expression of osteoprotegrin (OPG) and receptor activator of NF-κB ligand (RANKL) mRNA in osteoblastic UMR 106 cells. Both of them increased OPG mRNA and decreased RANKL mRNA expression, resulting in a dose-dependent increase in OPG/RANKL mRNA ratio (p<0.01, vs. vehicle-treated). Taken together, SWH treatment can effectively suppress the OVX-induced increase in bone turnover and its effects might be mediated by a decrease in osteoclastogenesis.]]></description><subject>Animals</subject><subject>Base Sequence</subject><subject>Biomechanical Phenomena</subject><subject>Body Weight - drug effects</subject><subject>Bone and Bones - drug effects</subject><subject>bone mineral density</subject><subject>bone strength OPG</subject><subject>Carrier Proteins - genetics</subject><subject>Cell Line</subject><subject>DNA Primers</subject><subject>Female</subject><subject>Glycoproteins - genetics</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Organ Size - drug effects</subject><subject>Osteoporosis - drug therapy</subject><subject>Osteoprotegerin</subject><subject>ovariectomized rat</subject><subject>Ovariectomy</subject><subject>RANK Ligand</subject><subject>RANKL</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Cytoplasmic and Nuclear - genetics</subject><subject>Receptors, Tumor Necrosis Factor - genetics</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Messenger - genetics</subject><subject>Sambucus</subject><subject>Sambucus williamsii</subject><subject>Uterus - drug effects</subject><issn>0918-6158</issn><issn>1347-5215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1v1DAQxS0EokvhxB1FQuJS7eJx4o8c21W_pEIlCicOluNMWq8Se7ETUPnr8TZLK3HhMpY1P783nkfIW6ArYJX62GybFVMrULJ-RhZQVnLJGfDnZEFrUEsBXB2QVyltKKWSsvIlOQDBaFWX9YJ8v_Q2oklYOF-cBI_FJ5NSYXw7327GiP52vCua--LGDM1kp1T8cn3vzJCcKy6OP69Pd2-vf5ro0I5hcL-xLb6YMb0mLzrTJ3yzPw_Jt7PTr-uL5dX1-eX6-GppJWNjrqCqjgpZddhaQMMs562iWHYdgGRKgKQt1igbEBatpUK1prVKNkZaWZeH5MOsu43hx4Rp1INLFvveeAxT0kIJXgpa_hfMPrwSDDL4_h9wE6bo8yc0VHlxHIRSmTqaKRtDShE7vY1uMPFeA9W7aHSORjOld9Fk-t1ec2oGbJ_YfRYZOJ-B3HXW9MH3zuOTs02ycaEPmlHKNaVMZRsK7EE-F8Uhb6ZmPCudzEqbNJpbfLQycXS2x8ex6L4-CPxt2jsTNfryD-Oetlo</recordid><startdate>20051001</startdate><enddate>20051001</enddate><creator>Xie, Fang</creator><creator>Wu, Chun-Fu</creator><creator>Zhang, Yan</creator><creator>Yao, Xin-Sheng</creator><creator>Cheung, Pik-Yuen</creator><creator>Chan, Albert Sun-Chi</creator><creator>Wong, Man-Sau</creator><general>The Pharmaceutical Society of Japan</general><general>Pharmaceutical Society of Japan</general><general>Japan Science and Technology Agency</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20051001</creationdate><title>Increase in Bone Mass and Bone Strength by Sambucus williamsii HANCE in Ovariectomized Rats</title><author>Xie, Fang ; Wu, Chun-Fu ; Zhang, Yan ; Yao, Xin-Sheng ; Cheung, Pik-Yuen ; Chan, Albert Sun-Chi ; Wong, Man-Sau</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c722t-c7184f0674fedc1ea2c55d80e3ff117286170de9e7b16cecc068dadc87ba7c793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Base Sequence</topic><topic>Biomechanical Phenomena</topic><topic>Body Weight - drug effects</topic><topic>Bone and Bones - drug effects</topic><topic>bone mineral density</topic><topic>bone strength OPG</topic><topic>Carrier Proteins - genetics</topic><topic>Cell Line</topic><topic>DNA Primers</topic><topic>Female</topic><topic>Glycoproteins - genetics</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Organ Size - drug effects</topic><topic>Osteoporosis - drug therapy</topic><topic>Osteoprotegerin</topic><topic>ovariectomized rat</topic><topic>Ovariectomy</topic><topic>RANK Ligand</topic><topic>RANKL</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Cytoplasmic and Nuclear - genetics</topic><topic>Receptors, Tumor Necrosis Factor - genetics</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Messenger - genetics</topic><topic>Sambucus</topic><topic>Sambucus williamsii</topic><topic>Uterus - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xie, Fang</creatorcontrib><creatorcontrib>Wu, Chun-Fu</creatorcontrib><creatorcontrib>Zhang, Yan</creatorcontrib><creatorcontrib>Yao, Xin-Sheng</creatorcontrib><creatorcontrib>Cheung, Pik-Yuen</creatorcontrib><creatorcontrib>Chan, Albert Sun-Chi</creatorcontrib><creatorcontrib>Wong, Man-Sau</creatorcontrib><creatorcontrib>aDepartment of Pharmacology</creatorcontrib><creatorcontrib>Shenyang Pharmaceutical University</creatorcontrib><creatorcontrib>Department of Applied Biology and Chemical Technology</creatorcontrib><creatorcontrib>The Hong Kong Polytechnic University</creatorcontrib><creatorcontrib>cState Key Laboratory of Chinese Medicine and Molecular Pharmacology</creatorcontrib><creatorcontrib>bOpen Laboratory of Chirotechnology of the Institute of Molecular Technology for Drug Discovery and Synthesis</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biological & Pharmaceutical Bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xie, Fang</au><au>Wu, Chun-Fu</au><au>Zhang, Yan</au><au>Yao, Xin-Sheng</au><au>Cheung, Pik-Yuen</au><au>Chan, Albert Sun-Chi</au><au>Wong, Man-Sau</au><aucorp>aDepartment of Pharmacology</aucorp><aucorp>Shenyang Pharmaceutical University</aucorp><aucorp>Department of Applied Biology and Chemical Technology</aucorp><aucorp>The Hong Kong Polytechnic University</aucorp><aucorp>cState Key Laboratory of Chinese Medicine and Molecular Pharmacology</aucorp><aucorp>bOpen Laboratory of Chirotechnology of the Institute of Molecular Technology for Drug Discovery and Synthesis</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increase in Bone Mass and Bone Strength by Sambucus williamsii HANCE in Ovariectomized Rats</atitle><jtitle>Biological & Pharmaceutical Bulletin</jtitle><addtitle>Biol Pharm Bull</addtitle><date>2005-10-01</date><risdate>2005</risdate><volume>28</volume><issue>10</issue><spage>1879</spage><epage>1885</epage><pages>1879-1885</pages><issn>0918-6158</issn><eissn>1347-5215</eissn><abstract><![CDATA[Herbal Sambucus williamsii HANCE (SWH) is a folk medicine with a long history of safe use for treatment of bone fractures and joint diseases in China. The present study was designed to investigate if SWH extract could be used for treatment of postmenopausal osteoporosis. SWH extracts (30 or 60 mg/100 g body weight/d) were orally administrated to four-months-old ovariectomized (OVX) rats for 3 months. SWH extracts did not alter weight gain and uterus weight in OVX rats. SWH extracts significantly increased serum Ca levels (p<0.05, vs. OVX control group) as well as decreased urinary Ca excretion (p<0.01, vs. OVX control group) in OVX rats. The upregulation of serum alkaline phosphatase, serum osteocalcin as well as urinary deoxypyridinoline levels by OVX was suppressed by treatment with SWH extracts in rats (p<0.05, vs. OVX control group). SWH extract increased the stiffness of femur at both dosage (p<0.05, vs. OVX control group) and increased tibial bone mineral density at 60 mg/100 g body weight/d (p<0.05, vs. OVX control group) in OVX rats. Our results indicate that orally administrated SWH extracts can decrease urinary calcium excretion and bone turnover rate in OVX rats, resulting in positive effects on biomechanical strength of bone and bone mineral density. This study is the first to report that SWH could be considered as a potential candidate for management of postmenopausal osteoporosis. Then in vitro experiments were performed to determine the potential molecular mechanism of the anti-osteoporotic effect of SWH. Results suggested that chloroform fraction and ethyl acetate fraction of SWH can inhibit osteoclastogenesis osteoclast by modulating the expression of osteoprotegrin (OPG) and receptor activator of NF-κB ligand (RANKL) mRNA in osteoblastic UMR 106 cells. Both of them increased OPG mRNA and decreased RANKL mRNA expression, resulting in a dose-dependent increase in OPG/RANKL mRNA ratio (p<0.01, vs. vehicle-treated). Taken together, SWH treatment can effectively suppress the OVX-induced increase in bone turnover and its effects might be mediated by a decrease in osteoclastogenesis.]]></abstract><cop>Japan</cop><pub>The Pharmaceutical Society of Japan</pub><pmid>16204939</pmid><doi>10.1248/bpb.28.1879</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0918-6158 |
| ispartof | Biological and Pharmaceutical Bulletin, 2005, Vol.28(10), pp.1879-1885 |
| issn | 0918-6158 1347-5215 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68653603 |
| source | J-STAGE Free; MEDLINE; EZB-FREE-00999 freely available EZB journals; Free Full-Text Journals in Chemistry |
| subjects | Animals Base Sequence Biomechanical Phenomena Body Weight - drug effects Bone and Bones - drug effects bone mineral density bone strength OPG Carrier Proteins - genetics Cell Line DNA Primers Female Glycoproteins - genetics Membrane Glycoproteins - genetics Organ Size - drug effects Osteoporosis - drug therapy Osteoprotegerin ovariectomized rat Ovariectomy RANK Ligand RANKL Rats Rats, Sprague-Dawley Receptors, Cytoplasmic and Nuclear - genetics Receptors, Tumor Necrosis Factor - genetics Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - genetics Sambucus Sambucus williamsii Uterus - drug effects |
| title | Increase in Bone Mass and Bone Strength by Sambucus williamsii HANCE in Ovariectomized Rats |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T04%3A44%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increase%20in%20Bone%20Mass%20and%20Bone%20Strength%20by%20Sambucus%20williamsii%20HANCE%20in%20Ovariectomized%20Rats&rft.jtitle=Biological%20&%20Pharmaceutical%20Bulletin&rft.au=Xie,%20Fang&rft.aucorp=aDepartment%20of%20Pharmacology&rft.date=2005-10-01&rft.volume=28&rft.issue=10&rft.spage=1879&rft.epage=1885&rft.pages=1879-1885&rft.issn=0918-6158&rft.eissn=1347-5215&rft_id=info:doi/10.1248/bpb.28.1879&rft_dat=%3Cproquest_cross%3E68653603%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1449351688&rft_id=info:pmid/16204939&rfr_iscdi=true |